logo-13-years

Articles from May 2007

Plavix®: Class 1 medicines recall 

The MHRA in conjunction with the EMEA, with assistance from sanofi-aventis and Bristol-Myers Squibb, are recalling parallel distributed stock of Lots 3098 and 6Y098 (and lot variants) of clopidogrel tablets 75mg branded as Plavix®, following the discovery of counterfeit tablets in the legitimate supply chain. (25 May 2007, www.mhra.gov.uk)

Zyprexa®: Class 1 medicines recall 

The MHRA in conjunction with the EMEA, with assistance from Eli Lilly and Company Ltd are recalling parallel distributed stock of Lots A200127, A216454 and A229505 (and lot variants) of olanzapine tablets 10mg branded as Zyprexa® following the discovery of counterfeit tablets in the legitimate supply chain. (24 May 2007, www.mhra.gov.uk)